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Abstract
Venous obstruction is relatively frequent following permanent pacemaker or implantable 
cardioverter-defibrillator (ICD) implantation. However, most of them are asymptomatic. 
Although the exact risk factor for this complication is not known, number of leads, heart 
failure and infection may prone the patient to this complication. The goal standard for 
detection of vein stenosis is venography; however, ultrasound sonography has an acceptable 
accuracy. Anticoagulant therapy may be considered for symptomatic patients. For device 
upgrading, non-functional leads removal, venoplasty and rarely surgical treatment may be 
indicated.
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With the growing numbers of pacemaker and implantable 
cardioverter defibrillator (ICD) implantations, obstruction 
of the access vein is detected more in these patients. Develop-
ment of thrombosis and obstruction is a multifactorial pro-
cess. Ligation of the access vein during cut-down approach, 
slowing of the flow in the vein due to decreased luminal area 
by the leads, and endothelial trauma caused by pacemak-
er leads, cause prothrombotic and inflammatory responses 
which may cause thrombus formation and subsequent scar-
ring that lead to obstruction [1].
In view of the diagnosis of lead-related thrombosis, two types 
of obstructions can be distinguished; few patients develop clin-
ically manifest obstructions with overt symptoms and signs, 
such as pain, tenderness, edema, warmth, paresthesia or bluish 
discoloration of ipsilateral arm. Pulmonary embolism and supe-
rior vena cava (SVC) syndrome are the two major but rare com-
plications of lead-related venous thrombosis in this group [2]. 
However, most of the patients have subclinical obstructions and 
in the absence of signs or symptoms, they are detected at fol-
low-up procedures such as system revision and lead extraction 
or during screening diagnostic imagines (Fig 1) [2].
It shows implantable cardioverter defibrillator lead fracture 
and totally obstruction of the left subclavian vein with col-
lateral formation in a 48 years old lady, 4 years after device 
implantation.
In prospective and retrospective studies, the incidence of 
significant venous obstruction was reported as 13.7-45% fol-
lowing endocardial lead insertion. However, clinically mani-
fested obstruction is relatively rare (1-3%) [3-5].
Figure 1: Fluoroscopy and venography in AP View
RISK FACTORS
Data about risk factors of venous obstruction after pacemak-
er implantation are conflicting and show many discrepancies. 
These conflicts may be due to different imaging modalities 
used for the detection of obstruction, length of their fol-
low-ups and different portions of each type of cardiac rhythm 
management device (PPM, ICD or CRT). In almost all the 
investigations, age, gender, smoking, lead size and cephalic 
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vs. subclavian approach were not found as risk factors for ve-
nous obstruction. Some studies determined number of leads, 
heart failure, female hormone use, personal history of venous 
thrombosis, and infection as risk factors. However, some oth-
er studies did not approve these correlations [3, 6, 7]. Pro-
phylaxis warfarin and antiplatelet consumption may lower 
the probability of venous stenosis [8].
DIAGNOSIS
Venography
Contrast venography is recognized as the standard method 
for diagnosis and is mostly performed before upgrading pro-
cedures. This method requires the use of ionizing radiation 
[9]. It can be performed by the injection of contrast medium 
through a large peripheral intravenous line [3].
Ultrasound Sonography
Ultrasound is most often used in patients with clinical signs 
or symptoms, because it is non-invasive, can easily be per-
formed at the bedside, and the patient does not get exposed 
to contrast medium or radiation. Non-compressibility, direct 
visualization of thrombus in the venous lumen and evalua-
tion of blood-flow can be used to establish the presence or 
absence of thrombosis in ultrasound sonography [10].
Computed Topography
Spiral computed topography (CT) venography is also an ac-
curate diagnostic tool which can detect deep vein thrombosis 
and require lesser amount of contrast medium compared to 
conventional venography. However, CT scan has not been 
validated for central chest veins [1]. Nonetheless, there are 
some reports aiming that this imaging modality can be help-
ful [11-13].
Magnetic Resonance Angiography
Magnetic resonance angiography was only evaluated in few 
studies with small sample sizes [10]. It is a non-invasive im-
aging modality that has acceptable accuracy for the detection 
of thrombus in the central thoracic veins and does not require 
contrast medium. Unfortunately, it is relatively contraindicat-
ed in the presence of a pacemaker or ICD [14].
MANAGEMENT
The strategy for the management of these patients depends 
on their signs, symptoms and clinical statuses. Since most 
patients with occlusion of subclavian vein are asymptomatic, 
and also few of them will require lead revision, or an ipsilater-
al lead insertion in future, obstruction does not develop any 
problem and does not need any management. A short-term 
warfarin therapy for 3-6 months is used after acute episodes 
of upper extremity deep vein thrombosis; however, there is 
no current recommendation to use warfarin as a primary pre-
vention after pacemaker leads implantation [1]. In the case 
of upgrade procedure, non-functional, old lead removal can 
restore the patency of previously occluded veins [15]. Suc-
cessful venoplasty of SVC, innominate or subclavian veins 
that may allow subsequent lead insertion was also reported 
[16]. In a few case reports, surgical treatments of pacemak-
er-related SVC syndromes that did not respond to treatment 
with anticoagulation or had contraindications to endovas-
cular procedure were performed successfully [17]. Surgical 
management requires thoracotomy and has high morbidity; 
so, should be considered as the last choice.
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